Clinical Trial Update: Determination of Optimum Duration of Treatment With Bromfenac (Xibrom) Eyedrops Following Cataract Surgery [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update examines the optimal duration of bromfenac (Xibrom) eye drops after cataract surgery.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cataracts

Drugs mentioned

• Xibrom (bromfenac)

Snippet

Sponsor: Bp Consulting, Inc | Conditions: Cataracts | Phase 4 | Status: COMPLETED